BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35182612)

  • 1. Tumor-permeable smart liposomes by modulating the tumor microenvironment to improve the chemotherapy.
    Widjaya AS; Liu Y; Yang Y; Yin W; Liang J; Jiang Y
    J Control Release; 2022 Apr; 344():62-79. PubMed ID: 35182612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
    Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells.
    Zhu Y; Wang A; Zhang S; Kim J; Xia J; Zhang F; Wang D; Wang Q; Wang J
    J Adv Res; 2023 Jul; 49():159-173. PubMed ID: 36167294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine.
    Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X
    Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer.
    Chen Y; Wang L; Luo S; Hu J; Huang X; Li PW; Zhang Y; Wu C; Tian BL
    Drug Des Devel Ther; 2020; 14():2945-2957. PubMed ID: 32801636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
    Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L
    ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy.
    Zhu Y; Liang J; Gao C; Wang A; Xia J; Hong C; Zhong Z; Zuo Z; Kim J; Ren H; Li S; Wang Q; Zhang F; Wang J
    J Control Release; 2021 Feb; 330():641-657. PubMed ID: 33359582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
    Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
    Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations.
    Ye J; Li R; Yang Y; Dong W; Wang Y; Wang H; Sun T; Li L; Shen Q; Qin C; Xu X; Liao H; Jin Y; Xia X; Liu Y
    J Nanobiotechnology; 2021 Jul; 19(1):199. PubMed ID: 34225762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug.
    Song P; Yao X; Zhong T; Zhang S; Guo Y; Ren W; Huang D; Duan XC; Yin YF; Zhang SS; Zhang X
    Oncotarget; 2016 Jul; 7(30):48467-48480. PubMed ID: 27366947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented EPR effect by photo-triggered tumor vascular treatment improved therapeutic efficacy of liposomal paclitaxel in mice bearing tumors with low permeable vasculature.
    Araki T; Ogawara K; Suzuki H; Kawai R; Watanabe T; Ono T; Higaki K
    J Control Release; 2015 Feb; 200():106-14. PubMed ID: 25553829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors.
    Danhier F; Danhier P; De Saedeleer CJ; Fruytier AC; Schleich N; des Rieux A; Sonveaux P; Gallez B; Préat V
    Int J Pharm; 2015 Feb; 479(2):399-407. PubMed ID: 25578367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity.
    Han B; Yang Y; Chen J; Tang H; Sun Y; Zhang Z; Wang Z; Li Y; Li Y; Luan X; Li Q; Ren Z; Zhou X; Cong D; Liu Z; Meng Q; Sun F; Pei J
    Int J Nanomedicine; 2020; 15():553-571. PubMed ID: 32158208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol).
    Fu H; Shi K; Hu G; Yang Y; Kuang Q; Lu L; Zhang L; Chen W; Dong M; Chen Y; He Q
    J Pharm Sci; 2015 Mar; 104(3):1160-73. PubMed ID: 25449709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Damaging Tumor Vessels with an Ultrasound-Triggered NO Release Nanosystem to Enhance Drug Accumulation and T Cells Infiltration.
    Xu Y; Liu J; Liu Z; Chen G; Li X; Ren H
    Int J Nanomedicine; 2021; 16():2597-2613. PubMed ID: 33833514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer.
    Zhang L; Wang Y; Yang Y; Liu Y; Ruan S; Zhang Q; Tai X; Chen J; Xia T; Qiu Y; Gao H; He Q
    ACS Appl Mater Interfaces; 2015 May; 7(18):9691-701. PubMed ID: 25845545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of tLyp-1 with polymeric paclitaxel conjugates: Enhanced intratumoral accumulation and anti-tumor efficacy.
    Liu Z; Huang Z; Ci L; Lu L; Liu Z; Yan X; Yan Z; Yu L; Liu Y; Lu W
    Pharmazie; 2017 Apr; 72(4):205-208. PubMed ID: 29441988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
    Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
    J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.